back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-07-17 Tx date 2017-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,107 vol |
30,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
15,000 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
36,107 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,618
+5,000 vol $2.52 each |
87,952 | |
| Filed 2016-11-15 Tx date 2016-11-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,950
+1,000 vol $4.95 each |
82,952 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
21,107 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
58 - Expiration of rights
|
$28,589
+7,986 vol $3.58 each |
81,952 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,589
+7,986 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,589
+7,986 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
||
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
$-33,616.20
-9,390 vol $3.58 each |
0 | |
| Filed 2016-05-18 Tx date 2016-05-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+1,000 vol $3.50 each |
73,966 | |
| Filed 2016-05-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
72,966 | ||
| Filed 2016-05-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
9,390 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
63,576 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
72,966 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Lee, Kenneth B Jr
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
6,107 |